IMNM vs KMB · $2.47B cap vs P/E 19, rev $8.35B
Immunome Inc (IMNM) versus Kimberly-Clark Corporation (KMB) — a side-by-side from cached financials, not a winner call.
Immunome Inc (IMNM) is a biotechnology company listed on US.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
Latest reported IMNM revenue for 2026-06-30 was $0. Net income was -$127.0M. IMNM currently screens at market cap $2.47B.
Latest reported KMB revenue for 2026-06-30 was $8.35B. Net income was $1.01B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
IMNM currently screens at market cap $2.47B. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
Not investment advice. Open the IMNM and KMB stock pages for the full models.
Not investment advice.